| 1 |
Subasi Turgut F, Karadag M, Taysi S, Hangül Z, Gokcen C. NRF2, KEAP1 and GSK-3 levels in autism spectrum disorder: a case control study. International Journal of Developmental Disabilities 2023. [DOI: 10.1080/20473869.2023.2185959] [Reference Citation Analysis]
|
| 2 |
López-Villatoro JM, Díaz-Marsá M, De la Torre-Luque A, MacDowell KS, Prittwitz C, Leza JC, Carrasco JL. Inflammatory and oxidative endophenotypes in borderline personality disorder: A biomarker cluster analysis. World J Biol Psychiatry 2023;:1-8. [PMID: 36919867 DOI: 10.1080/15622975.2023.2183254] [Reference Citation Analysis]
|
| 3 |
Zuo C, Cao H, Song Y, Gu Z, Huang Y, Yang Y, Miao J, Zhu L, Chen J, Jiang Y, Wang F. Nrf2: An all-rounder in depression. Redox Biology 2022;58:102522. [DOI: 10.1016/j.redox.2022.102522] [Reference Citation Analysis]
|
| 4 |
He L, Zheng Y, Huang L, Ye J, Ye Y, Luo H, Chen X, Yao W, Chen J, Zhang JC. Nrf2 regulates the arginase 1(+) microglia phenotype through the initiation of TREM2 transcription, ameliorating depression-like behavior in mice. Transl Psychiatry 2022;12:459. [PMID: 36316319 DOI: 10.1038/s41398-022-02227-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 5 |
Wei Y, Chang L, Liu G, Wang X, Yang Y, Hashimoto K. Long-lasting beneficial effects of maternal intake of sulforaphane glucosinolate on gut microbiota in adult offspring. J Nutr Biochem 2022;:109098. [PMID: 35788394 DOI: 10.1016/j.jnutbio.2022.109098] [Reference Citation Analysis]
|
| 6 |
Cao Q, Zou Q, Zhao X, Zhang Y, Qu Y, Wang N, Murayama S, Qi Q, Hashimoto K, Lin S, Zhang JC. Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity. Cell Death Discov 2022;8:267. [PMID: 35595779 DOI: 10.1038/s41420-022-01063-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 7 |
Zheng W, Li X, Zhang T, Wang J. Biological mechanisms and clinical efficacy of sulforaphane for mental disorders. Gen Psychiatr 2022;35:e100700. [PMID: 35492261 DOI: 10.1136/gpsych-2021-100700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Subba R, Ahmad MH, Ghosh B, Mondal AC. Targeting NRF2 in Type 2 diabetes mellitus and depression: Efficacy of natural and synthetic compounds. Eur J Pharmacol 2022;:174993. [PMID: 35513015 DOI: 10.1016/j.ejphar.2022.174993] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Tang R, Cao QQ, Hu SW, He LJ, Du PF, Chen G, Fu R, Xiao F, Sun YR, Zhang JC, Qi Q. Sulforaphane activates anti-inflammatory microglia, modulating stress resilience associated with BDNF transcription. Acta Pharmacol Sin 2022;43:829-39. [PMID: 34272506 DOI: 10.1038/s41401-021-00727-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 10 |
Morris G, Sominsky L, Walder KR, Berk M, Marx W, Carvalho AF, Bortolasci CC, Maes M, Puri BK. Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia. Mol Neurobiol 2022. [PMID: 35347586 DOI: 10.1007/s12035-022-02800-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Beeraka NM, Avila-Rodriguez MF, Aliev G. Recent Reports on Redox Stress-Induced Mitochondrial DNA Variations, Neuroglial Interactions, and NMDA Receptor System in Pathophysiology of Schizophrenia. Mol Neurobiol 2022. [PMID: 35083660 DOI: 10.1007/s12035-021-02703-4] [Reference Citation Analysis]
|
| 12 |
Cecerska-Heryć E, Polikowska A, Serwin N, Roszak M, Grygorcewicz B, Heryć R, Michalczyk A, Dołęgowska B. Importance of oxidative stress in the pathogenesis, diagnosis, and monitoring of patients with neuropsychiatric disorders, a review. Neurochem Int 2021;153:105269. [PMID: 34971747 DOI: 10.1016/j.neuint.2021.105269] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 13 |
Faborode OS, Dalle E, Mabandla MV. Exposure to footshock stress downregulates antioxidant genes and increases neuronal apoptosis in an Aβ(1-42) rat model of Alzheimer's disease. Neurochem Int 2021;150:105170. [PMID: 34419526 DOI: 10.1016/j.neuint.2021.105170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 14 |
Morris G, Gamage E, Travica N, Berk M, Jacka FN, O'Neil A, Puri BK, Carvalho AF, Bortolasci CC, Walder K, Marx W. Polyphenols as adjunctive treatments in psychiatric and neurodegenerative disorders: Efficacy, mechanisms of action, and factors influencing inter-individual response. Free Radic Biol Med 2021;172:101-22. [PMID: 34062263 DOI: 10.1016/j.freeradbiomed.2021.05.036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 15 |
Özbey NP, Thompson MA, Taylor RC. The regulation of animal behavior by cellular stress responses. Exp Cell Res 2021;405:112720. [PMID: 34217715 DOI: 10.1016/j.yexcr.2021.112720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Ahmed A, Misrani A, Tabassum S, Yang L, Long C. Minocycline inhibits sleep deprivation-induced aberrant microglial activation and Keap1-Nrf2 expression in mouse hippocampus. Brain Res Bull 2021;174:41-52. [PMID: 34087360 DOI: 10.1016/j.brainresbull.2021.05.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 17 |
Wang X, Liu J, Dai Z, Sui Y. Andrographolide improves PCP-induced schizophrenia-like behaviors through blocking interaction between NRF2 and KEAP1. J Pharmacol Sci 2021;147:9-17. [PMID: 34294378 DOI: 10.1016/j.jphs.2021.05.007] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 18 |
Qu Y, Shan J, Wang S, Chang L, Pu Y, Wang X, Tan Y, Yamamoto M, Hashimoto K. Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling. Eur Arch Psychiatry Clin Neurosci 2021;271:439-46. [PMID: 33180200 DOI: 10.1007/s00406-020-01208-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 19 |
Stenvinkel P, Meyer CJ, Block GA, Chertow GM, Shiels PG. Understanding the role of the cytoprotective transcription factor nuclear factor erythroid 2-related factor 2-lessons from evolution, the animal kingdom and rare progeroid syndromes. Nephrol Dial Transplant 2020;35:2036-45. [PMID: 31302696 DOI: 10.1093/ndt/gfz120] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 20 |
Bhandari R, Kaur J, Kaur S, Kuhad A. The Nrf2 pathway in psychiatric disorders: pathophysiological role and potential targeting. Expert Opin Ther Targets 2021;25:115-39. [PMID: 33557652 DOI: 10.1080/14728222.2021.1887141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Yao W, Lin S, Su J, Cao Q, Chen Y, Chen J, Zhang Z, Hashimoto K, Qi Q, Zhang JC. Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents. Transl Psychiatry 2021;11:140. [PMID: 33627628 DOI: 10.1038/s41398-021-01261-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 22 |
Ermakov EA, Dmitrieva EM, Parshukova DA, Kazantseva DV, Vasilieva AR, Smirnova LP. Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives. Oxid Med Cell Longev 2021;2021:8881770. [PMID: 33552387 DOI: 10.1155/2021/8881770] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 23 |
Yoshino Y, Roy B, Kumar N, Shahid Mukhtar M, Dwivedi Y. Molecular pathology associated with altered synaptic transcriptome in the dorsolateral prefrontal cortex of depressed subjects. Transl Psychiatry 2021;11:73. [PMID: 33483466 DOI: 10.1038/s41398-020-01159-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 24 |
Morris G, Walker AJ, Walder K, Berk M, Marx W, Carvalho AF, Maes M, Puri BK. Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry. Mol Neurobiol 2021;58:2158-82. [PMID: 33411248 DOI: 10.1007/s12035-020-02212-w] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 25 |
Shah P, Gupta GL. Convolvulus pluricaulis usage and depression. The Neuroscience of Depression 2021. [DOI: 10.1016/b978-0-12-817935-2.00001-5] [Reference Citation Analysis]
|
| 26 |
Pereira AC, Oliveira J, Silva S, Madeira N, Pereira CMF, Cruz MT. Inflammation in Bipolar Disorder (BD): Identification of new therapeutic targets. Pharmacol Res 2021;163:105325. [PMID: 33278569 DOI: 10.1016/j.phrs.2020.105325] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 27 |
Luan D, Zhao MG, Shi YC, Li L, Cao YJ, Feng HX, Zhang ZJ. Mechanisms of repetitive transcranial magnetic stimulation for anti-depression: Evidence from preclinical studies. World J Psychiatr 2020; 10(10): 223-233 [PMID: 33134113 DOI: 10.5498/wjp.v10.i10.223] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 28 |
Zhang J, Chang L, Pu Y, Hashimoto K. Abnormal expression of colony stimulating factor 1 receptor (CSF1R) and transcription factor PU.1 (SPI1) in the spleen from patients with major psychiatric disorders: A role of brain-spleen axis. J Affect Disord 2020;272:110-5. [PMID: 32379601 DOI: 10.1016/j.jad.2020.03.128] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 29 |
Wu C, Chen X, Lai J, Xu Y, Hu S. The efficacy and safety of sulforaphane as an adjuvant in the treatment of bipolar depressive disorder: Study protocol for a randomized, double-blinded, placebo-controlled, parallel-group clinical trial. Medicine (Baltimore) 2020;99:e20981. [PMID: 32590809 DOI: 10.1097/MD.0000000000020981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 30 |
Morris G, Walder KR, Berk M, Marx W, Walker AJ, Maes M, Puri BK. The interplay between oxidative stress and bioenergetic failure in neuropsychiatric illnesses: can we explain it and can we treat it? Mol Biol Rep 2020;47:5587-620. [PMID: 32564227 DOI: 10.1007/s11033-020-05590-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 31 |
Zhang J, Tan Y, Chang L, Hammock BD, Hashimoto K. Increased expression of soluble epoxide hydrolase in the brain and liver from patients with major psychiatric disorders: A role of brain - liver axis. J Affect Disord 2020;270:131-4. [PMID: 32339103 DOI: 10.1016/j.jad.2020.03.070] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 32 |
Rossetti AC, Paladini MS, Riva MA, Molteni R. Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention. Pharmacol Ther 2020;210:107520. [PMID: 32165136 DOI: 10.1016/j.pharmthera.2020.107520] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 33 |
Morris G, Puri BK, Carvalho A, Maes M, Berk M, Ruusunen A, Olive L. Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought? Int J Neuropsychopharmacol 2020;23:366-84. [PMID: 32034911 DOI: 10.1093/ijnp/pyaa008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 34 |
MacDowell KS, Marsá MD, Buenache E, Villatoro JML, Moreno B, Leza JC, Carrasco JL. Inflammatory and antioxidant pathway dysfunction in borderline personality disorder. Psychiatry Res 2020;284:112782. [PMID: 31955054 DOI: 10.1016/j.psychres.2020.112782] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 35 |
Ibi M, Yabe-nishimura C. The role of reactive oxygen species in the pathogenic pathways of depression. Oxidative Stress and Dietary Antioxidants in Neurological Diseases 2020. [DOI: 10.1016/b978-0-12-817780-8.00001-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 36 |
Morris G, Puri BK, Walker AJ, Berk M, Walder K, Bortolasci CC, Marx W, Carvalho AF, Maes M. The compensatory antioxidant response system with a focus on neuroprogressive disorders. Prog Neuropsychopharmacol Biol Psychiatry 2019;95:109708. [PMID: 31351160 DOI: 10.1016/j.pnpbp.2019.109708] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 37 |
Zhang K, Fujita Y, Chang L, Qu Y, Pu Y, Wang S, Shirayama Y, Hashimoto K. Abnormal composition of gut microbiota is associated with resilience versus susceptibility to inescapable electric stress. Transl Psychiatry 2019;9:231. [PMID: 31530799 DOI: 10.1038/s41398-019-0571-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 38 |
Ma A, Hong J, Shanks J, Rudebush T, Yu L, Hackfort BT, Wang H, Zucker IH, Gao L. Upregulating Nrf2 in the RVLM ameliorates sympatho-excitation in mice with chronic heart failure. Free Radic Biol Med 2019;141:84-92. [PMID: 31181253 DOI: 10.1016/j.freeradbiomed.2019.06.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 39 |
Hashimoto K. Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings. Curr Psychiatry Rep 2019;21:75. [PMID: 31278495 DOI: 10.1007/s11920-019-1063-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 40 |
Arioz BI, Tastan B, Tarakcioglu E, Tufekci KU, Olcum M, Ersoy N, Bagriyanik A, Genc K, Genc S. Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway. Front Immunol 2019;10:1511. [PMID: 31327964 DOI: 10.3389/fimmu.2019.01511] [Cited by in Crossref: 150] [Cited by in F6Publishing: 157] [Article Influence: 37.5] [Reference Citation Analysis]
|
| 41 |
Pu Y, Qu Y, Chang L, Wang SM, Zhang K, Ushida Y, Suganuma H, Hashimoto K. Dietary intake of glucoraphanin prevents the reduction of dopamine transporter in the mouse striatum after repeated administration of MPTP. Neuropsychopharmacol Rep 2019;39:247-51. [PMID: 31132231 DOI: 10.1002/npr2.12060] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 42 |
Xiong Z, Zhang K, Ren Q, Chang L, Chen J, Hashimoto K. Increased expression of inwardly rectifying Kir4.1 channel in the parietal cortex from patients with major depressive disorder. J Affect Disord 2019;245:265-9. [PMID: 30419525 DOI: 10.1016/j.jad.2018.11.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 43 |
Hashimoto K. Essential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future Perspective. Front Pharmacol. 2018;9:1182. [PMID: 30386243 DOI: 10.3389/fphar.2018.01182] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 44 |
Li S, Yang C, Fang X, Zhan G, Huang N, Gao J, Xu H, Hashimoto K, Luo A. Role of Keap1-Nrf2 Signaling in Anhedonia Symptoms in a Rat Model of Chronic Neuropathic Pain: Improvement With Sulforaphane. Front Pharmacol 2018;9:887. [PMID: 30135655 DOI: 10.3389/fphar.2018.00887] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 45 |
Matsuura A, Ishima T, Fujita Y, Iwayama Y, Hasegawa S, Kawahara-Miki R, Maekawa M, Toyoshima M, Ushida Y, Suganuma H, Kida S, Yoshikawa T, Iyo M, Hashimoto K. Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation. Sci Rep 2018;8:2158. [PMID: 29391571 DOI: 10.1038/s41598-018-20538-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
|
